Tag Archives: Available

FDA real-world evidence to be made available on Google Cloud

Google announced this week that it will make the U.S. Food & Drug Administration’s open-source MyStudies platform available on the Google Cloud Platform. WHY IT MATTERSThe goal, said Jameson Rogers, product manager at Google Cloud Healthcare & Life Sciences, is “stimulate an open ecosystem that will improve the ability of organizations to perform research that… Read More »

Brexanolone (Zulresso) for Postpartum Depression Cleared by the DEA, Now Available

Brexanolone, to be marketed by Sage Therapeutics as Zulresso, was initially approved in March 2019, as a treatment for postpartum depression.  At that time, we were told that Zulresso would be available in June 2019. Here are a few updates. The Drug Enforcement Administration (DEA) has recommended that brexanolone be placed in schedule IV of… Read More »